Tilray Inc (NASDAQ:TLRY)

44.25
Delayed Data
As of 3:59pm ET
 -0.16 / -0.36%
Today’s Change
20.10
Today|||52-Week Range
300.00
-37.27%
Year-to-Date
Should You Buy a Cannabis ETF?
12:24pm / Zacks.com - Paid Partner Content
The 6 Best Marijuana Stocks in June
Jul 08 / MotleyFool.com - Paid Partner Content
U.S. CBD Sales to Grow an Average of 107% Annually Through 2023
Jul 14 / MotleyFool.com - Paid Partner Content
Thinking about buying stock in Aethlon Medical, Alibaba, Canopy Growth, Eros Internat...
Jul 02 / PR NewswirePRN - Paid Partner Content
3 Pot Stocks Short-Sellers Are Targeting
Jul 11 / MotleyFool.com - Paid Partner Content
Blueberries Announces Appointment of Chief Financial Officer
Jun 24 / GlobeNewswirePNW - Paid Partner Content

Today’s Trading

Previous close44.41
Today’s open44.37
Day’s range44.06 - 45.48
Volume972,867
Average volume (3 months)1,638,057
Market cap$4.2B
Data as of 3:59pm ET, 07/17/2019

Growth & Valuation

Earnings growth (last year)-873.51%
Earnings growth (this year)-26.73%
Earnings growth (next 5 years)--
Revenue growth (last year)+110.00%
P/E ratioNM
Price/Sales135.76
Price/Book20.43

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...+1.59+1.68%
MRNAModerna Inc-0.11-0.78%
ONCESpark Therapeutics I...-0.65-0.67%
ALLOAllogene Therapeutic...+0.51+1.84%
Data as of 4:00pm ET, 07/17/2019

Financials

Next reporting dateAugust 28, 2019
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$43.1M
Annual profit (last year)-$67.7M
Net profit margin-157.02%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Brendan Kennedy
Executive Vice President-
Operations
Greg Christopher
Corporate headquarters
Nanaimo, British Columbia

Forecasts